Commentary

Commentary

Cell-and-Gene-Therapy

Cell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession

Cell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession

AdobeStock_230441943

Developing a digital people strategy to harness the power of generative AI

Artificial intelligence is a science and applied technology that involves deductive processing and machine learning subsequently performing human-like tasks

Legalise-Cannabis

Part 4. UK routes to registration for medicinal cannabis

Final article in a four part series considering uses of medicinal cannabis

Cannabis&Doctors

Part 3. The medical applications of cannabis

Third in a four part series considering uses of medicinal cannabis

Cannabis&Law

Part 2. Regulatory background of medicinal cannabis in EU and UK

Second in a four part series considering uses of medicinal cannabis

AdobeStock_434233415

Part 1. An introduction
to medicinal cannabis

The first in a four part series considering uses of medicinal cannabis

Science is more than you think

‘Science is more than
a body of knowledge’

How the Regulatory Rapporteur’s online platform will provide its online journal experience

Feb-24-Podcast-artwork-Webvision

RegRapPod − February 2024

2024-02-20T16:51:00+00:00